There was talk that The Maze Runner: Death Cure film was on a permanent hiatus after Dylan O’Brien sustained a severe injury on set last March. Because of the severity of the injuries, Fox halted production to allow the star time to heal. They were originally planning on resuming filming in May, but decided to push it back to give O’Brien more time to recuperate. The question that was on everyone’s minds, however, was if production would resume at all. Today we received confirmation of the production schedule for the film.
As confirmed by Deadline today, it looks like Fox is planning on resuming production of the film next February. The film’s release date has been pushed back from February 17, 2017, to January 12, 2018. After the second round of postponement, the crew that was attached to the film went their own separate ways due to concerns about production ever being resumed. Schedules have been cemented in place, however, to finish off the rest of the production for the film. The only change that we know of is that the location where filming will be taking place is different.
The Maze Runner: Death Cure film will be the final film in the trilogy. Although there is no official synopsis yet for the film, we have the synopsis from the novel available here:
It’s the end of the line. WICKED has taken everything from Thomas: his life, his memories, and now his only friends—the Gladers. But it’s finally over. The trials are complete, after one final test.
Will anyone survive?
What WICKED doesn’t know is that Thomas remembers far more than they think. And it’s enough to prove that he can’t believe a word of what they say. The truth will be terrifying.
Thomas beat the Maze. He survived the Scorch. He’ll risk anything to save his friends. But the truth might be what ends it all.
The time for lies is over.
What do you think about this new information? Do you think Fox should have just stopped production? How do you think the delayed timing in production will influence the success of the film? Let us know in the comments below.